BRIGUGLIO, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 312
NA - Nord America 207
AS - Asia 112
SA - Sud America 28
AF - Africa 3
Totale 662
Nazione #
US - Stati Uniti d'America 205
RU - Federazione Russa 166
SE - Svezia 42
SG - Singapore 40
CN - Cina 37
IE - Irlanda 34
BR - Brasile 27
FR - Francia 17
VN - Vietnam 11
DE - Germania 10
HK - Hong Kong 10
IT - Italia 9
GB - Regno Unito 7
FI - Finlandia 6
UA - Ucraina 6
BE - Belgio 5
IN - India 5
NL - Olanda 3
CA - Canada 2
ES - Italia 2
KG - Kirghizistan 2
PH - Filippine 2
PL - Polonia 2
AL - Albania 1
AR - Argentina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IQ - Iraq 1
MA - Marocco 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 662
Città #
Moscow 41
Dublin 33
Ashburn 29
Chandler 25
Singapore 24
Beijing 20
Dallas 19
Nyköping 17
Jacksonville 16
Ann Arbor 11
Hong Kong 10
The Dalles 10
Los Angeles 6
Brussels 5
Hanoi 5
New York 5
Woodbridge 5
Buffalo 4
Cambridge 4
Medford 4
Princeton 4
Pune 4
San Mateo 4
Boardman 3
Lauterbourg 3
San Jose 3
São Paulo 3
Tianjin 3
Amsterdam 2
Bishkek 2
Chicago 2
Des Moines 2
Duque de Caxias 2
Frankfurt am Main 2
Grammichele 2
Helsinki 2
Ho Chi Minh City 2
Lanzhou 2
Manchester 2
Nanchang 2
Santa Clara 2
Taizhou 2
Wilmington 2
Aracaju 1
Araxá 1
Araçatuba 1
Barnet 1
Bebedouro 1
Ben Arous 1
Blida 1
Bremen 1
Burzaco 1
Cabo Frio 1
Campina Grande 1
Chennai 1
City of London 1
Da Nang 1
Denver 1
Düsseldorf 1
Harrisburg 1
Imus 1
Ipatinga 1
Izmir 1
Jenin 1
Lajeado 1
Leawood 1
Macaé 1
Manaus 1
Meknes 1
Montes Claros 1
Montreal 1
Nasiriyah 1
Newburgh 1
Ningbo 1
Nova Russas 1
Nova Serrana 1
Olomouc 1
Paracambi 1
Paraíso do Tocantins 1
Phoenix 1
Quận Ba 1
Ratoath 1
Ribeirão Preto 1
Riyadh 1
Roubaix 1
Santana de Parnaíba 1
Sapucaia do Sul 1
Surprise 1
São José dos Campos 1
Taboão da Serra 1
Tashkent 1
Tirana 1
Toronto 1
Uberlândia 1
Ubá 1
Warsaw 1
Wroclaw 1
Zamboanga City 1
Zhengzhou 1
Zoetermeer 1
Totale 407
Nome #
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. 170
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 164
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 146
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. 134
null 52
Totale 666
Categoria #
all - tutte 1.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.953


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 4 8 3
2021/202237 1 4 0 3 0 0 2 2 0 14 2 9
2022/202398 9 12 4 5 6 11 3 3 41 0 4 0
2023/202426 0 4 0 2 2 9 7 0 0 1 0 1
2024/202590 0 3 1 5 1 6 0 12 29 8 13 12
2025/2026304 19 23 15 18 20 68 42 49 44 6 0 0
Totale 666